Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.

Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.

Howard Fuchs, MD, professor of Medicine, Division of Rheumatology and Immunology, died unexpectedly Oct. 28. He was 64.

Vanderbilt University Medical Center recently debuted a new clinic dedicated to providing a multidisciplinary approach to caring for patients coping with the complex host of chronic disorders known as vasculitis.

A new clinical trial by investigators at Vanderbilt University Medical Center (VUMC) and other leading medical centers found that an intensive transplant treatment using the patient’s own stem cells can improve survival and quality of life for patients with advanced scleroderma.

An enzyme that produces bioactive fatty acids has elevated activity in patients with rheumatoid arthritis, supporting further studies to understand its biologic roles in the disease.

Taylor Brumbelow has a gift for quickly putting people at ease.